These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Subcutaneous injection of the HIV-1 fusion inhibitor enfuvirtide (FUZEON) may result in soft-tissue accumulation of Tc-99m MDP. Pack LE; Zuckier LS Clin Nucl Med; 2012 Jan; 37(1):100-1. PubMed ID: 22157043 [No Abstract] [Full Text] [Related]
8. Enfuvirtide: patient acceptance and strategies for managing injection-site reactions. Rice C; Wilantewicz H AIDS Read; 2006 Sep; 16(9):470-4, 490-1. PubMed ID: 17024766 [TBL] [Abstract][Full Text] [Related]
9. Transient neuropathy after needle-free injection outside of recommended sites. Harris M; Larsen G; Valyi M; Walker E; Montaner JS AIDS; 2006 Mar; 20(5):784-5. PubMed ID: 16514315 [No Abstract] [Full Text] [Related]
10. [Combined treatment with fusion inhibitor. HIV-1 viruses under control longer]. MMW Fortschr Med; 2004 Apr; 146(15):68. PubMed ID: 15373030 [No Abstract] [Full Text] [Related]
11. A novel form of amyloid deposited at the site of enfuvirtide injection. Naujokas A; Vidal CI; Mercer SE; Harp J; Kurtin PJ; Fox LP; Thompson MM J Cutan Pathol; 2012 Feb; 39(2):220-1; quiz 219. PubMed ID: 22264247 [No Abstract] [Full Text] [Related]
12. Enfuvirtide doubles chances for suppression. AIDS Patient Care STDS; 2004 Sep; 18(9):550. PubMed ID: 15630779 [No Abstract] [Full Text] [Related]
13. Relapse of intravenous drug use triggered by enfuvirtide, a parenteral antiretroviral medication. Avelino-Silva VI; Li HY; Novaes CT AIDS Patient Care STDS; 2012 Feb; 26(2):71-2. PubMed ID: 22148866 [TBL] [Abstract][Full Text] [Related]
14. T-1249 development suspended. Huff B GMHC Treat Issues; 2003 Dec; 17(12):6. PubMed ID: 15011643 [No Abstract] [Full Text] [Related]
15. New partnership calls for clinical testing of two fusion inhibitors. Slovick J Posit Living; 1999 Aug; 8(7):15, 62. PubMed ID: 12492078 [No Abstract] [Full Text] [Related]
16. Localized amyloidosis at the site of enfuvirtide injection. Morilla ME; Kocher J; Harmaty M Ann Intern Med; 2009 Oct; 151(7):515-6. PubMed ID: 19805777 [No Abstract] [Full Text] [Related]
18. Enfuvirtide: a new class of antiretroviral therapy for HIV infection. Leao JC; Frezzini C; Porter S Oral Dis; 2004 Nov; 10(6):327-9. PubMed ID: 15533206 [TBL] [Abstract][Full Text] [Related]
20. A prospective clinical and pathological examination of injection site reactions with the HIV-1 fusion inhibitor enfuvirtide. Myers SA; Selim AA; McDaniel MA; Hall R; Zhang Y; Bartlett JA; True AL Antivir Ther; 2006; 11(7):935-9. PubMed ID: 17302257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]